Daniel E. Salazar
Greater Baltimore Medical Center(US)
Publications by Year
Research Areas
Antiplatelet Therapy and Cardiovascular Diseases, Pharmacogenetics and Drug Metabolism, Advanced Multi-Objective Optimization Algorithms, Lipoproteins and Cardiovascular Health, Analytical Methods in Pharmaceuticals
Most-Cited Works
- → Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel(2007)727 cited
- → Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation(2010)342 cited
- → Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently(2007)321 cited
- → Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel(2008)315 cited
- → Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass(1988)250 cited
- → Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers(2004)179 cited